Showing results (441-450 of 863) with videos related to
Sort By:
Pageof 87
Med (New York, N.Y.)|January 10, 2026
BETting on the future: BET inhibition for patients with lymphomaTimothy J Voorhees, Catherine C CoombsMed (New York, N.Y.)|January 10, 2026
Depression, cognition, and GLP-1 receptors: Heterogeneity and therapeutic prospectsMu-Hong Chen, Ya-Mei Bai, Shih-Jen TsaiMed (New York, N.Y.)|February 7, 2026
Incidence and spectrum of immune-related adverse events in nasopharyngeal carcinoma patients treated with immune checkpoint inhibitorsKun-Peng Wu, Xu-Qiang Luo, Pei-Xin Tan, et al.Med (New York, N.Y.)|December 13, 2025
Beyond TIGIT: Lessons from a failed immune checkpoint for rational target discoveryJiatong Ding, Shuhang Wang, Ning LiMed (New York, N.Y.)|April 12, 2025
Bridging the gaps: Overcoming challenges of implementing AI in healthcareXiaoyun Huang, Lei Gu, Jian Sun, et al.Med (New York, N.Y.)|April 12, 2025
B cell depletion in lupus nephritis: From disappointments to hopes, despite some concernsAntoine Enfrein, Frédéric A HoussiauMed (New York, N.Y.)|May 27, 2025
Anti-BCMA CAR-T cell therapy in relapsed/refractory chronic inflammatory demyelinating polyneuropathyMing-Hao Dong, Zhi-Cheng Mei, Luo-Qi Zhou, et al.Med (New York, N.Y.)|May 28, 2025
Epidural electrical stimulation facilitates motor recovery in spinal cord injury involving the conus medullaris: A case studyLuigi Albano, Daniele Emedoli, Filippo Agnesi, et al.Med (New York, N.Y.)|May 24, 2025
Pre-treatment untargeted cerebrospinal fluid metabolomic profiling in tuberculous meningitis uncovers pathways associated with mortalityThanh Hoang Nhat Le, Kirsten C J van Abeelen, Edwin Ardiansyah, et al.Med (New York, N.Y.)|May 10, 2025
Learning from the LEAP trial series: Optimizing clinical trial design for combination therapiesJiatong Ding, Yue Yu, Dandan Cui, et al.Pageof 87